Schizophrenia-like reduced sensorimotor gating in intact inbred and outbred rats is associated with decreased medial prefrontal cortex activity and volume.
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
15
01
2019
accepted:
07
04
2019
revised:
02
04
2019
pubmed:
16
4
2019
medline:
7
7
2020
entrez:
16
4
2019
Statut:
ppublish
Résumé
Prepulse inhibition (PPI) of startle response is a measure of sensorimotor gating that is impaired in schizophrenia and in many other clinical conditions. Rat models using pharmacological or surgical strategies reveal that PPI is modulated by the cortico-striatal-pallido-thalamic (CSPT) circuit. Here, we explore whether spontaneous variation in PPI in intact inbred and outbred rats is associated with functional and structural differences in the CSPT circuit. Inbred Roman High-(RHA) and Low-avoidance (RLA) and outbred heterogeneous stock (HS) rats were assessed for PPI, brain activity, and brain volume. Brain activity was assessed by c-Fos expression and brain volume by magnetic resonance imaging. Relevant structures of the CSPT circuit were evaluated, such as the medial prefrontal cortex (mPFC), cingulate cortex, hippocampus (HPC), amygdala, nucleus accumbens (NAc), and dorsal striatum. RHA showed lower PPI than RLA rats, while HS rats were stratified by their PPI levels in three groups. Reduced PPI was accompanied by decreased mPFC activity in Roman and HS rats and increased NAc shell activity in HS rats. Low PPI was also associated with decreased mPFC and HPC volumes in Roman and HS rats. This study reports a consistent relationship between decreased function and volume of the mPFC and spontaneous low-PPI levels in inbred and outbred intact rats. Moreover, our findings suggest that, apart from a hypoactive and smaller mPFC, a hyperactive NAc and smaller HPC may underlie reduced PPI levels. Our results support the notion that sensorimotor gating is modulated by forebrain structures and highlight the importance of the mPFC in its regulation.
Identifiants
pubmed: 30986819
doi: 10.1038/s41386-019-0392-x
pii: 10.1038/s41386-019-0392-x
pmc: PMC6784988
doi:
Substances chimiques
Proto-Oncogene Proteins c-fos
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1975-1984Références
Nature. 2004 Jan 22;427(6972):311-2
pubmed: 14737157
Exp Neurol. 2005 Sep;195(1):185-98
pubmed: 15935347
Neuroscience. 2009 Mar 3;159(1):21-30
pubmed: 19141315
Prog Neurobiol. 1999 Oct;59(2):107-28
pubmed: 10463792
Alcohol Clin Exp Res. 1984 Sep-Oct;8(5):477-9
pubmed: 6391259
Brain Res Bull. 2001 Jan 15;54(2):145-51
pubmed: 11275403
J Psychiatr Res. 2013 Apr;47(4):445-52
pubmed: 23287742
Curr Biol. 2011 Dec 20;21(24):2109-14
pubmed: 22169537
Schizophr Bull. 1998;24(2):285-301
pubmed: 9613626
J Neurosci. 2014 Jun 4;34(23):7931-46
pubmed: 24899715
J Neurosci. 2014 Nov 5;34(45):14948-60
pubmed: 25378161
Neurogastroenterol Motil. 2005 Aug;17(4):548-56
pubmed: 16078944
Behav Brain Res. 2013 Nov 15;257:129-39
pubmed: 24095878
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:174-84
pubmed: 25220677
Neuropsychiatr Dis Treat. 2007 Feb;3(1):87-101
pubmed: 19300540
Cereb Cortex. 2017 Sep 1;27(9):4447-4462
pubmed: 27550864
Science. 2002 Apr 26;296(5568):692-5
pubmed: 11976442
Psychopharmacology (Berl). 2016 Jun;233(12):2373-81
pubmed: 27095448
Physiol Behav. 1999 Aug 1;67(1):19-26
pubmed: 10463624
Behav Brain Res. 2004 Jul 9;152(2):187-97
pubmed: 15196786
Front Behav Neurosci. 2015 Jul 10;9:174
pubmed: 26217201
Synapse. 2007 Jun;61(6):391-400
pubmed: 17372984
Front Biosci. 2001 Sep 01;6:D1069-72
pubmed: 11532605
Psychopharmacology (Berl). 2001 Jul;156(2-3):117-54
pubmed: 11549216
Curr Top Behav Neurosci. 2016;28:305-25
pubmed: 27311762
Physiol Behav. 2016 Mar 1;155:195-201
pubmed: 26700617
Neurosci Biobehav Rev. 2007;31(1):148-63
pubmed: 17164110
Behav Genet. 2009 Jan;39(1):48-61
pubmed: 18972198
Brain Res. 1997 Oct 31;773(1-2):45-52
pubmed: 9409703
Cortex. 2008 Oct;44(9):1206-14
pubmed: 18761134
Physiol Behav. 2016 Sep 1;163:267-273
pubmed: 27184235
Neuropsychopharmacology. 2005 Apr;30(4):683-96
pubmed: 15688091
Behav Brain Res. 2014 Apr 1;262:74-83
pubmed: 24406716
Neuroscience. 2001;103(2):325-35
pubmed: 11246148
Brain Stimul. 2013 Jul;6(4):490-9
pubmed: 23085443
Pharmacol Biochem Behav. 1994 Sep;49(1):155-63
pubmed: 7816867
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:17-30
pubmed: 25455585
Behav Neurosci. 2002 Feb;116(1):72-84
pubmed: 11895185
Schizophr Res. 2014 Feb;152(2-3):503-12
pubmed: 24405980
Pharmacol Biochem Behav. 2007 May;87(1):1-10
pubmed: 17475315
Eur Neuropsychopharmacol. 2017 Feb;27(2):146-158
pubmed: 28049558
Psychopharmacology (Berl). 2001 Jul;156(2-3):194-215
pubmed: 11549223
Psychophysiology. 1975 May;12(3):238-48
pubmed: 1153628
Biol Psychiatry. 2011 Nov 1;70(9):842-51
pubmed: 21816387
Int J Neuropsychopharmacol. 2013 Sep;16(8):1819-34
pubmed: 23574629
Neuroscience. 2014 Mar 28;263:36-45
pubmed: 24412375
Psychophysiology. 1978 Jul;15(4):339-43
pubmed: 693742
Neurobiol Dis. 2013 Nov;59:126-40
pubmed: 23891727
Mol Neurobiol. 2018 Mar;55(3):1998-2012
pubmed: 28265857
Front Behav Neurosci. 2015 Aug 18;9:213
pubmed: 26347624
Neuropsychopharmacology. 2010 Nov;35(12):2346-56
pubmed: 20686455
Neuroscientist. 2012 Aug;18(4):320-5
pubmed: 22013150
Behav Brain Res. 2019 Apr 1;361:74-85
pubmed: 30576720
Neuroimage. 2005 Jul 15;26(4):1052-8
pubmed: 15961045
Psychopharmacology (Berl). 1995 Aug;120(4):433-41
pubmed: 8539324
Neurosci Biobehav Rev. 2004 May;28(3):273-83
pubmed: 15225971
J Neurochem. 2010 Jun;113(5):1123-32
pubmed: 20236391
Brain Res. 1996 May 25;722(1-2):168-76
pubmed: 8813362
Neuroscience. 1999 Mar;89(3):965-78
pubmed: 10199628
Behav Processes. 2018 Jun;151:96-103
pubmed: 29567400
Psychopharmacology (Berl). 1999 Jun;144(4):347-54
pubmed: 10435407
Eur J Neurosci. 1994 Dec 1;6(12):1837-45
pubmed: 7704295
Exp Neurol. 2016 Sep;283(Pt A):142-50
pubmed: 27302677
Neuroscience. 2006 Sep 1;141(3):1113-21
pubmed: 16750891
Neuropharmacology. 2017 Mar 15;115:128-138
pubmed: 26987983
J Neurosci Methods. 2005 Jan 30;141(1):9-20
pubmed: 15585284
Schizophr Res. 2015 Jun;165(1):45-51
pubmed: 25864953
Psychopharmacology (Berl). 2001 Jul;156(2-3):225-33
pubmed: 11549225
Biol Psychiatry. 2007 Jul 15;62(2):148-57
pubmed: 17027927
Nat Genet. 2013 Jul;45(7):767-75
pubmed: 23708188
Psychiatry Res. 2003 Feb 15;122(2):99-113
pubmed: 12714174